Sofinnova Investments, Inc. Q2 2020 Filing
Filed August 13, 2020
Portfolio Value
$1.6T
Holdings
76
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (76 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics, Inc. | 1,885,602 | $210.2B | 13.25% | |
| 2 | ASNDAscendis Pharma A/S | 1,109,874 | $164.2B | 10.35% | |
| 3 | NTRANatera | 3,100,560 | $154.6B | 9.75% | |
| 4 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $94.8B | 5.98% | |
| 5 | —Principia Biopharma | 1,417,258 | $84.7B | 5.34% | |
| 6 | NXTCNextcure, Inc | 2,671,856 | $57.3B | 3.61% | |
| 7 | AMGNAmgen Inc | 168,500 | $39.7B | 2.51% | Put |
| 8 | UTHUnited Therapeutics Corp | 304,562 | $36.9B | 2.32% | |
| 9 | AMRNAmarin | 5,208,305 | $36.0B | 2.27% | |
| 10 | MRKMerck & Co Inc | 451,178 | $34.9B | 2.20% | |
| 11 | CHRSCoherus BioSciences | 1,933,221 | $34.5B | 2.18% | |
| 12 | —Akouos, Inc | 1,515,073 | $34.1B | 2.15% | |
| 13 | GILDGilead Sciences Inc | 403,494 | $31.0B | 1.96% | |
| 14 | —ObsEva SA | 4,749,623 | $28.0B | 1.76% | |
| 15 | JAZZJazz Pharmaceuticals PLC | 243,353 | $26.9B | 1.69% | |
| 16 | ABBVAbbvie Inc | 251,959 | $24.7B | 1.56% | |
| 17 | LLYEli Lilly & Co | 148,900 | $24.4B | 1.54% | |
| 18 | PTCTPTC Therapeutics Inc | 438,270 | $22.2B | 1.40% | |
| 19 | ALNYAlnylam Pharmaceuticals Inc | 150,000 | $22.2B | 1.40% | Call |
| 20 | GRTXGalera Therapeutics, Inc | 3,083,712 | $22.0B | 1.39% | |
| 21 | MRUSMerus N.V. | 1,311,039 | $21.1B | 1.33% | |
| 22 | XLRNAcceleron Pharma Inc | 217,390 | $20.7B | 1.31% | |
| 23 | KNSAKiniksa Pharmaceuticals, Ltd | 809,803 | $20.6B | 1.30% | |
| 24 | LVLNSPDR Ser Tr | 150,000 | $16.8B | 1.06% | Put |
| 25 | HZNPHorizon Therapeutics PLC | 252,958 | $14.1B | 0.89% | |
| 26 | TGTXTG Therapeutics Inc | 696,390 | $13.6B | 0.86% | |
| 27 | IM8NInsmed Inc | 483,967 | $13.3B | 0.84% | |
| 28 | —Nucana Biomed Ltd | 2,400,000 | $13.0B | 0.82% | |
| 29 | PBYIPuma Biotechnology Inc | 1,197,630 | $12.5B | 0.79% | |
| 30 | —Nucana Biomed Ltd | 2,266,666 | $12.3B | 0.77% | |
| 31 | SUPNSupernus Pharmaceuticals Inc | 478,329 | $11.4B | 0.72% | |
| 32 | —Zymeworks Inc | 299,734 | $10.8B | 0.68% | |
| 33 | —MyoKardia Inc | 111,810 | $10.8B | 0.68% | |
| 34 | MIRMMirum Pharmaceuticals Inc | 541,701 | $10.5B | 0.66% | |
| 35 | AQLTiShares Tr | 70,000 | $10.0B | 0.63% | Put |
| 36 | KURAKura Oncology Inc | 610,979 | $10.0B | 0.63% | |
| 37 | AKBAAkebia Therapeutics Inc | 681,892 | $9.3B | 0.58% | |
| 38 | —Chiasma | 1,630,221 | $8.8B | 0.55% | |
| 39 | XLFISelect Sector SPDR Tr | 84,700 | $8.5B | 0.53% | Put |
| 40 | —Kadmon Holdings Inc | 1,530,864 | $7.8B | 0.49% | |
| 41 | BMRNBiomarin Pharmaceutical Inc | 62,897 | $7.8B | 0.49% | |
| 42 | QQQInvesco QQQ Trust | 30,000 | $7.4B | 0.47% | Put |
| 43 | 2L9Blueprint Medicines Corp | 94,891 | $7.4B | 0.47% | |
| 44 | AXSMAxsome Therapeutics Inc | 86,978 | $7.2B | 0.45% | |
| 45 | LQDALiquidia Technologies Inc | 800,000 | $6.7B | 0.42% | |
| 46 | XLFISPDR Ser Tr | 65,300 | $6.5B | 0.41% | Put |
| 47 | BCRXBioCryst Pharmaceuticals Inc | 1,357,848 | $6.5B | 0.41% | |
| 48 | —Applied Genetic Technologies Corp | 1,145,254 | $6.3B | 0.40% | |
| 49 | —Constellation Pharmaceuticals Inc | 207,087 | $6.2B | 0.39% | |
| 50 | ITCIEURIntra-Cellular Therapies Inc | 241,908 | $6.2B | 0.39% | |
| 51 | OTICEUROtonomy Inc | 1,651,411 | $6.0B | 0.38% | |
| 52 | PTGXProtagonist Therapeutics Inc | 326,064 | $5.8B | 0.36% | |
| 53 | PFEPfizer Inc | 175,000 | $5.7B | 0.36% | Call |
| 54 | —Intra-Cellular Therapies Inc | 220,000 | $5.6B | 0.36% | Put |
| 55 | CCXIEURChemoCentryx Inc | 96,916 | $5.6B | 0.35% | |
| 56 | —Calithera Biosciences Inc | 1,040,399 | $5.5B | 0.35% | |
| 57 | KALAKala Pharmaceuticals Inc | 506,647 | $5.3B | 0.34% | |
| 58 | FIXXEURHomology Medicines Inc | 344,579 | $5.2B | 0.33% | |
| 59 | CYTKCytokinetics Inc | 160,217 | $3.8B | 0.24% | |
| 60 | —Entasis Therapeutics Holdings Inc. | 1,180,178 | $3.5B | 0.22% | |
| 61 | —Mersana Therapeutics Inc | 137,966 | $3.2B | 0.20% | |
| 62 | ACRSAclaris Therapeutics | 1,911,573 | $3.1B | 0.20% | |
| 63 | PTCTPTC Therapeutics Inc | 60,000 | $3.0B | 0.19% | Call |
| 64 | NVCRNovocure Ltd | 50,000 | $3.0B | 0.19% | Call |
| 65 | RETAEURReata Pharmaceuticals Inc | 13,035 | $2.0B | 0.13% | |
| 66 | APLSApellis Pharmaceuticals, Inc | 49,580 | $1.6B | 0.10% | |
| 67 | CGENCompugen Ltd | 103,587 | $1.6B | 0.10% | |
| 68 | SNDXSyndax Pharmaceuticals Inc | 91,964 | $1.4B | 0.09% | |
| 69 | —Menlo Therapeutics Inc | 725,571 | $1.3B | 0.08% | |
| 70 | NTLAIntellia Therapeutics Inc | 57,500 | $1.2B | 0.08% | |
| 71 | —Synlogic Inc. | 574,972 | $1.2B | 0.07% | |
| 72 | IMVTImmunovant Inc | 40,513 | $987.0M | 0.06% | |
| 73 | MRTXEURMirati Therapeutics Inc | 8,072 | $922.0M | 0.06% | |
| 74 | ARNAEURArena Pharmaceuticals Inc | 13,929 | $877.0M | 0.06% | |
| 75 | RIGLUSDRigel Pharmaceuticals Inc | 339,695 | $622.0M | 0.04% | |
| 76 | ORICOric Pharmaceuticals Inc | 17,369 | $585.0M | 0.04% | |
| 77 | PDSBPDS Biotechnology Corporation | 142,635 | $287.0M | 0.02% |